Literature DB >> 22934827

Downstream processing of lentiviral vectors: releasing bottlenecks.

Vanessa Bandeira1, Cristina Peixoto, Ana F Rodrigues, Pedro E Cruz, Paula M Alves, Ana S Coroadinha, Manuel J T Carrondo.   

Abstract

Lentiviral vectors (LVs) hold great potential as gene delivery vehicles. However, the manufacturing and purification of these vectors still present major challenges, mainly because of the low stability of the virus, essentially due to the fragility of the membrane envelope. The main goal of this work was the establishment of a fast, scalable, and robust downstream protocol for LVs, combining microfiltration, anion-exchange, and ultrafiltration membrane technologies toward maximization of infectious LVs recovery. CIM(®) (Convective Interaction Media) monolithic columns with diethylaminoethanol (DEAE) anion exchangers were used for the purification of clarified LV supernatants, allowing infectious vector recoveries of 80%, which is 10% higher than the values currently reported in the literature. These recoveries, combined with the results obtained after optimization of the remaining downstream purification steps, resulted in overall infectious LV yields of 36%. Moreover, the inclusion of a Benzonase step allowed a removal of approximately 99% of DNA impurities. The entire downstream processing strategy herein described was conceived based on disposable and easily scalable technologies. Overall, CIM DEAE columns have shown to be a good alternative for the purification of LVs, since they allow faster processing of the viral bulks and enhanced preservation of virus biological activity, consequently, increasing infectious vector recoveries.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22934827     DOI: 10.1089/hgtb.2012.059

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  18 in total

Review 1.  Downstream processing and chromatography based analytical methods for production of vaccines, gene therapy vectors, and bacteriophages.

Authors:  Petra Kramberger; Lidija Urbas; Aleš Štrancar
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Real-time transfer of lentiviral particles by producer cells using an engineered coculture system.

Authors:  Lauren M Timmins; Riya S Patel; Matthew S Teryek; Biju Parekkadan
Journal:  Cytotechnology       Date:  2019-09-12       Impact factor: 2.058

3.  A scalable method to concentrate lentiviral vectors pseudotyped with measles virus glycoproteins.

Authors:  M P Marino; M Panigaj; W Ou; J Manirarora; C-H Wei; J Reiser
Journal:  Gene Ther       Date:  2015-01-22       Impact factor: 5.250

4.  Production and Use of Gesicles for Nucleic Acid Delivery.

Authors:  Mathias Mangion; Marc-André Robert; Igor Slivac; Rénald Gilbert; Bruno Gaillet
Journal:  Mol Biotechnol       Date:  2021-10-01       Impact factor: 2.695

5.  Cancer Gene Therapy: Development and Production of Lentiviral Vectors for Gene Therapy.

Authors:  Ana S Coroadinha
Journal:  Methods Mol Biol       Date:  2022

6.  Development of isoporous microslit silicon nitride membranes for sterile filtration applications.

Authors:  Evan Wright; Joshua J Miller; Matthew Csordas; Andrew R Gosselin; Jared A Carter; James L McGrath; David R Latulippe; James A Roussie
Journal:  Biotechnol Bioeng       Date:  2019-12-18       Impact factor: 4.530

7.  Evaluation of Host Cell Impurity Effects on the Performance of Sterile Filtration Processes for Therapeutic Viruses.

Authors:  Evan Wright; Karina Kawka; Maria Fe C Medina; David R Latulippe
Journal:  Membranes (Basel)       Date:  2022-03-24

8.  Evaluation of novel large cut-off ultrafiltration membranes for adenovirus serotype 5 (Ad5) concentration.

Authors:  Piergiuseppe Nestola; Duarte L Martins; Cristina Peixoto; Susanne Roederstein; Tobias Schleuss; Paula M Alves; José P B Mota; Manuel J T Carrondo
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

9.  Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34(+) Cells Correlates With In Vivo Vector Copy Number.

Authors:  Naoya Uchida; Molly E Evans; Matthew M Hsieh; Aylin C Bonifacino; Allen E Krouse; Mark E Metzger; Stephanie E Sellers; Cynthia E Dunbar; Robert E Donahue; John F Tisdale
Journal:  Mol Ther Nucleic Acids       Date:  2013-09-17       Impact factor: 10.183

10.  Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column.

Authors:  Ashok Raj Kattur Venkatachalam; Milene Szyporta; Tanja Kristin Kiener; Premanand Balraj; Jimmy Kwang
Journal:  Virol J       Date:  2014-05-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.